Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs-Reference-Cited by-同舟云学术

Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs

Published:2010-04-01 Issue:4 Volume:120 Page:1140-1150
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Townsend DeWayne,Turner Immanuel,Yasuda Soichiro,Martindale Joshua,Davis Jennifer,Shillingford Michael,Kornegay Joe N.,Metzger Joseph M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference55 articles.

1. Emery AEH, Muntoni F. Clinical features. In: Emery AEH, ed.Duchenne Muscular Dystrophy . Oxford, United Kingdom: Oxford University Press; 2003:26–45.

2. Dystrophin: The protein product of the duchenne muscular dystrophy locus

3. Managing Duchenne muscular dystrophy – The additive effect of spinal surgery and home nocturnal ventilation in improving survival

4. The Heart in Human Dystrophinopathies

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Effectiveness of Poloxamer 188 in Dystrophic Cardiomyopathy Reveals Complex Pathophysiology;2024-09-07

2. Early Natural History of Cardiomyopathy and Cardiac Stress Response in Young Dogs with Golden Retriever Muscular Dystrophy;2024-08-20

3. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response;Cells;2024-07-09

4. Systemic Treatment of Body‐Wide Duchenne Muscular Dystrophy Symptoms;Clinical Pharmacology & Therapeutics;2024-07-04

5. Cardioprotection by Poloxamer 188 is Mediated through Increased Endothelial Nitric Oxide Production;2024-05-20